Acasti Pharma Inc (ACST) Quote

ACST to GRCE, 10/28/2024

ACST................................https://stockcharts.com/h-sc/ui?s=ACST&p=W&b=5&g=0&id=p86431144783

$ACST: Thats good news.... now 0.67

EF Hutton gave them a $2.50 Target.


Hmmmmmmmmmmmmmmmmm



Looking for an entry here


GO $ACST

Acasti Pharma Announces Preliminary Topline Results Met All Primary Outcome Measures in the Single Dose Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia (PHN)
https://www.acasti.com/en/investors/news-events/press-releases/detail/239/acasti-pharma-announces-preliminary-topline-results-met-all

News. Premarket volume.

ACST

Bid filled @ 88 new low.

ACST

Bid filled @ 88 new low.

ACST

ACST Acasti Pharma Price Target announced at $6.00 by Oppenheimer. 12/21/20

ACST...$1.69...Psar flipped Bullish on the second Highest Green Volume Day in the history of ACST...

Chart... https://schrts.co/VuKYQNpa ...

ACST...$1.64s clearing here...:partying_face:

SEC 424B5 > We have entered into a sales agreement with B. Riley Securities, Inc., Oppenheimer & Co. Inc., and H.C. Wainwright & Co., LLC (collectively the “Agents” and each an “Agent”), relating to the sale of our common shares, no par value per common share, offered by this prospectus supplement. In accordance with the terms of the sales agreement, we may offer and sell from time to time our common shares having an aggregate offering price of up to US$75,000,000 through or to the Agents, each acting as sales agent or principal.

DUMPED all my shares at 1.40

ACST...$1.41...in the P/M...plus 27%...:partying_face: https://www.benzinga.com/analyst-ratings/price-target/21/12/24728317/acasti-pharma-shares-spike-higher-after-hours-as-oppenheimer-initiates-coverage-on-s

LOADED THE BOAT AT 1.04

LOADED MORE AT 1.10

LOADED AT 1.16

Loaded MORE at 1.20

Let’s do this

LOADED THE BOAT at $1.52.

Let’s do this.

ACST - Acasti Pharma Awarded Composition-of-Matter Patents for GTX-101 in Europe, China and Mexico and for GTX-102 in Japan
Acasti Pharma, Inc.
Wed, October 6, 2021, 8:30 AM

Patents strengthen Acasti’s IP portfolio and provide protection through 2036 and 2037, respectively

LAVAL, Québec, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announces that the European Patent Office, Chinese Patent Office and the Mexican Patent Office have issued composition of matter patents for GTX-101, a novel bio-adhesive film forming topical spray formulation of bupivacaine for the treatment of Postherpetic Neuralgia (PHN). PHN is a persistent and often debilitating neuropathic pain caused by nerve damage from the varicella zoster virus (shingles), which may persist for months and even years. GTX-101 could provide significant benefits over the current standard of care including greater convenience, faster onset of action and longer duration of pain relief. The granted patents are valid until 2036.

In addition, the Japanese Patent Office has granted a composition of matter patent for GTX-102, a novel, easy-to-use oral mucosal spray formulation of betamethasone, intended to improve neurological symptoms of Ataxia-telangiectasia (A-T). A-T is a progressive, neurodegenerative genetic disease that primarily affects children causing severe physical disability, for which no treatment currently exists. The granted patent is valid until 2037.

Jan D’Alvise, Chief Executive Officer of Acasti, stated, “These latest patents are important additions to our intellectual property portfolio, expanding product protection to additional important international markets as we continue to progress these drug candidates through clinical studies. We believe these granted composition of matter patents further support the commercial potential of GTX-101 and GTX-102. Both drug candidates have already received Orphan Drug Designation from the FDA and could address important underserved global markets. The goal of these proprietary formulations is to improve the quality of care and patient outcomes by providing significant efficacy, safety and convenience benefits including ease of use, faster onset of action and extended relief.”

https://finance.yahoo.com/news/acasti-pharma-awarded-composition-matter-123000390.html

Loaded $1.98, let’s ??

ACST...$2.22...Bullish Descent Block Reversal Pattern to the Upside formed on this Oversold Pincher Squeeze set up...imo...we shall see...

Adding here on the post split dip...

Chart... https://schrts.co/rWzDkaBw ...

Hard to catch a falling knife.

The price could easily decline below $2. Maybe not today, but over a period of days.

Back in.

ACST

You ain't kidding. All the shareholders prior to the reverse split are selling to salvage what they can.

INDEFATIGABLE DUMPING

Watch after RS.


ACST

ACST/ACSTX...$30.40...1/8 Reverse Split...https://www.otcmarkets.com/filing/html?id=15192357&guid=iOP9kW-VfXy9sth

LAVAL, Québec, Aug. 27, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti”) (NASDAQ: ACST–TSX-V: ACST), announced today the completion of its previously disclosed acquisition of Grace Therapeutics, Inc. (“Grace”) via merger. The successful completion of the merger positions Acasti to build a premier, late-stage specialty pharma company focused on rare diseases. Based on management’s current forecasts, Acasti expects to have enough cash on its balance sheet following the merger to provide at least two years of operating runway. The combined companies will be led by Jan D’Alvise as President and Chief Executive Officer, under the oversight of Acasti’s newly elected Board of Directors, comprised of four re-elected directors of Acasti and two Grace nominees newly elected as directors (with a third Grace nominee expected to be nominated prior to the next annual meeting of shareholders). All Grace employees will transition to Acasti and they will continue to maintain a research and development laboratory and commercial presence in North Brunswick, New Jersey.

Very nice premarket..

ACST

Got some...

ACST

I am as well...

Still holding a nice position here.


ACST

ACST...4668...Forming a strong confirmation candle following the Bullish Doji Star on the close from yesterday...imo...we shall see...:partying_face:

Adding some back here.


ACST

ACST...57...in the P/M...on the Gappa...:partying_face:

"As part of the Acasti annual and special meeting, Acasti will be seeking the shareholder approvals necessary to complete the merger, elect directors and for other related matters. The 2021 annual and special meeting of Acasti shareholders will be held virtually on August 26, 2021, at 1:00 p.m. (Eastern Time), unless postponed or adjourned to a later date."

When is the merger?

Premarket looking very nice. Let's see if we can crack $1.00 near term.

Form S-4/A - https://newsfilter.io/articles/s-4a-form---amend-registration-of-securities-business-combinations---acasti-pharma-inc-0001444192-fi-13bc4f13124dae71b281efeaa56a65fc

ACST
Here we go !!


Nice pop !!!

watch $AMIH to breakout coming there to

Definitely looks to be shaping up nicely.
Next week. Couple weeks. Whatever.

It’s all good.
In fact. Life is great.

We are blessed to be in the position we’re in.
Where our biggest worry is how soon we’ll bank lol

Have a great weekend !!!


ACST

Looks like a good week coming next week ,,

Going to get that push again and it's going to be a good one.


ACST

Buying time on this one

If you're not trading this one around a core, you're missing out on a lot of profits.


Been a great money maker.


ACST

https://www.streetinsider.com/dr/news.php?id=18634612&gfv=1

ACST...5997...:partying_face:

Let's make some money today. Happy trading!!!

Gap was at 563 to 573...ACST...5779...in the P/M...Gap filled yesterday...:party:
[8:04 AM]
georgie18 — Yesterday at 7:41 AM
ACST...57...in the P/M...Added here in this range...Looking for the .56 dip n rip on the Gap Fill...imo...we shall see...:party:

Gap at .59 no reason we should not hit that today.